AI-driven pharma supply chain planning platform PLAIO has raised EUR 4.3 million (USD 4.7 million) in a funding round led by Iðunn, a venture capital fund managed by Kvika Asset Management. Other key investors include Dr. Agon.
The funds will be used to expand the company’s operations across the US and Europe, enhance its AI Coplanner tool, and forge strategic partnerships to cement its market leadership position.
Based in Iceland, PLAIO specializes in digitizing demand, manufacturing, and purchase planning processes for generic pharmaceutical manufacturers. The company’s platform is designed to optimize the production planning cycle by integrating various complex variables specific to pharmaceutical manufacturing, including regulatory and compliance requirements. PLAIO's key product features include visual and capacity planning, AI-driven predictive analytics, and automation tools that help manufacturers achieve precise and agile production outputs.
By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.